Search
Leukemia patients may do better on CAR T cell therapy when they are treated early, before their disease relapses.
Evidence from a recent study, led by MSK urologic surgeon, Behfar Ehdaie, MD, MPH, indicates that more patients with favorable Grade Group 2 prostate cancer can be successfully managed with active surveillance and achieve acceptable oncologic outcomes, even if later treatment is required.
Nationally known cancer researcher and clinician Craig B. Thompson was named the new President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center in August 2010. He also becomes President of Gerstner Sloan Kettering Graduate School of Biomedical Sciences.
Cancer doesn’t stop for a pandemic, but as local governments around the nation mandated the stoppage of elective surgery, Memorial Sloan Kettering Cancer Center (MSK) surgeons had to consider several critical questions.
Total gastrectomy is indicated for patients with stomach cancer gene mutations regardless of family history.
For the first time, a genetic link specific to risk of childhood leukemia has been identified, according to a team of researchers from Memorial Sloan Kettering Cancer Center, St. Jude Children’s Research Hospital, University of Washington, and other institutions.
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Lopez was recognized for his positive impact on New York City through his professional, communal, and philanthropic achievements.
Meet MSK Director of Social Work Penny Damaskos and learn how she and her team help people with cancer.
A new type of engineered immune cell could be a potent treatment for cancers that have escaped other immunotherapies.